Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liothyronine replacement therapy in STEMI patients with low or borderline free T3
2009-010869-23Phase 2Active
- Sponsor
- Fondazione Toscana Gabriele Monasterio
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of liothyronine in myocardial infarction (MI) (2 arms), sponsored by Fondazione Toscana Gabriele Monasterio. Primary endpoint: Major and minor adverse cardiac events. Started Mar 2009; status: active.
02
Drugs
liothyronine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-010869-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010869-23.